-+ 0.00%
-+ 0.00%
-+ 0.00%

AARD Deadline Alert: SueWallSt Reminds Aardvark Therapeutics, Inc. (AARD) Investors of Securities Class Action Deadline on October 13, 2026

Barchart·09/17/2026 09:09:00
Listen to the news

Dated chronology: from a $16.00 IPO in February 2025 to a Phase 3 pause and a full FDA clinical hold, a securities class action alleges Aardvark Therapeutics' ARD-101 safety representations unraveled while AARD shares fell to $4.57.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.